A CROSS-SECTIONAL STUDY ON SODIUM VALPROATE, CARBAMAZEPINE, AND LEVETIRACETAM INDUCING ENURESIS IN EPILEPTIC CHILDREN
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i1.42923Keywords:
Enuresis, Antiepileptics., Adverse drug reaction, ChildrenAbstract
Objectives: Enuresis or bedwetting is considered to be an underreported ADR of antiepileptic drugs (AEDs). This study assesses the incidence and comparative rate of occurrence of enuresis in children with epilepsy who are on AEDs treatment such as sodium valproate (SV); carbamazepine and levetiracetam (LEV).
Methods: The study was conducted with a sample size of 32 patients. Both inpatients and outpatients between the age group >5–18 years of age previously diagnosed with epilepsy that is on monotherapy and polytherapy with SV or carbamazepine or LEV were included in the study. Patients with urinary complications or urogenital abnormalities past 3 months before admission were excluded from the study. Assessment of enuresis was done based on a questionnaire prepared from NICE guidelines and analyzed using SPSS software version 20.
Results: Of 44 patients who were included in the study, only 34 came for review. Analysis of the questionnaire showed the occurrence of enuresis in 12 patients. Drugs prescribed versus assessment questions showed potent significance with eight questions; hence the hypothesis that the prescribed drugs can cause enuresis can be taken into consideration. The rate of occurrence of enuresis was analyzed in all the drugs with their respective doses, but the significant values were found only for SV 200 mg.
Conclusion: This study shows the possibility of enuresis in LEV and SV treatment with a significant difference in SV. Furthermore, it showed a relation between the duration of treatment and the occurrence of enuresis.
Downloads
References
Stafstrom CE, Carmant L. Seizures and epilepsy: An overview for neuroscientists. Cold Spring Harb Perspect Med 2015;5:a022426.
Anna R, Salvatore M, Renzo G. Antiepileptic drug treatment in children with epilepsy. CNS Drugs 2015;29:847-63.
Arda E, Cakiroglu B, Thomas DT. Primary nocturnal enuresis: A review. Nephrourol Mon 2016;8:e35809.
Baird DC, Seehusen DA, Bode DV. Enuresis in children: A case-based approach. Am Fam Physician 2014;90:560-8.
Soren R, Konstantinos K. In: Israel F, Paul F, Stuart B, Alexander G, Yves H, editors. Pediatric Incontinence: Evaluation and Clinical Management: Hoboken, New Jersey: John Wiley and Sons; 2015. p. 209-19.
Reza SB, Arash A, Mahmoud RA, Fakhreddin S, Omid B. The effect of sodium valproate on urinary frequency and enuresis compared to carbamazepine in children with epilepsy. Iran. J. Pediatr 2018;26:e66083-7.
Gosavi D, Akanksha S, Manish J. Sodium valproate induced increased frequency of micturition and enuresis. Indian J Pharmacol 2013;45:87-8.
Al-Waili NS. Carbamazepine to treat primary nocturnal enuresis:A double-blind study. Eur J Med Res 2000;5:40-4.
Hmouda H, Salem CB, Grira M, Slim R, Bouraoui K. Carbamazepine-induced urinary retention. Br J Clin Pharmacol 2007;64:833-4.
Tekgül H, Gencpinar P, Cavusoglu D, Dündar NO. The efficacy, tolerability, and safety of levetiracetam therapy in a pediatric population. Seizure 2016;36:16-21.
Faruk I, Ozlem MH, Seyda B, Sakir A. Urinary and fecal incontinence during levetiracetam therapy. Ann Indian Acad Neurol 2015;18:479-80.
Aaron PB, Steven JS. Nocturnal enuresis: An approach to assessment and treatment. Pediatr Rev 2014;35:327-35.
Geng H, Wang CZ. Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: A meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat 2017;13:685-95.
Suman A, Gosavi DD. Study of adverse drug effects of antiepileptic drugs used in pediatric patients in a tertiary care rural hospital a pharmacovigilance study. J Young Pharm 2017;9:60-6.
Linehan C, Kerr M. Epidemiology of epilepsy in developed countries. In: Benbadis SR, Beran RG, Berg AT, Engel J Jr., Galanopoulou AS, Kaplan PW, editors. Atlas of Epilepsies. Berlin, Heidelberg: Springer; 2010. p. 51-6.
Raj HD, Sylvia A, Chidambaranathan S, Nirmala P. Monotherapy and polytherapy in paediatric seizures: A prospective, observational study in a tertiary care teaching hospital. Int Arch Integer Med 2017;4:97-104.
Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Carotenut OG. Primary nocturnal enuresis as a risk factor for sleep disorders: An observational questionnaire-based multicenter study. Neuropsychiatr Dis Treat 2013;9:437-43.
Ramakrishnan K, Krishnan K. Evaluation and treatment of enuresis. Am Fam Physician 2008;78:489-96.
Zrubavel CV, Kushnir B, Kushnir J, Sadeh A. Sleep and sleepiness in children with nocturnal enuresis. Sleep 2011;34:191-4.
Nevéus T. The amount of urine voided in bed by children with enuresis. J Pediatr Urol 2019;15:31.
Thiedk CC. Nocturnal enuresis. Am Fam Physician 2003;67:1499-506.
Vande J, Vande WC, Van SP, De GA, Raes A, Donckerwolcke R. Nocturnal polyuria is related to 24‐hour diuresis and osmotic excretion in an enuresis population referred to a tertiary center. J Urol 2007;178:2630-4.
Pomeranz A, Abu‐Kheat G, Korzets Z, Wolach B. Night‐time polyuria and urine hypo‐osmolality in enuretics identified by nocturnal sequential urine sampling: Do they represent a subset of relative ADH‐deficient subjects? Scand J Urol 2000;34:199-202.
Dehoorne JL, Raes AM, Van LE, Hoebeke P, Vande Walle JG. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion. J Urol 2006;176:749-53.
Aikawa T, Kasahara T, Uchiyama M. The arginine vasopressin secretion profile of children with primary nocturnal enuresis. Eur Urol Suppl 1998;33:41-6.
Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. BMJ 1981;283:577-81.
Herranz JL, Arteaga R, Armijo JA. Side effects of sodium valproate in monotherapy controlled by plasma levels: A study in 88 pediatric patients. Epilepsia 1982;23:203-14.
Yamak WR, Hmaimess G, Makke Y, Sabbagh S, Arabi M, Beydoun A. Valproate-induced enuresis: A prospective study. Dev Med Child Neurol 2015;57:737-41.
Malik AM, Usmani A. Day time urinary incontinence due to valproate in a patient with idiopathic generalized tonic-clonic seizures. J Med Case Rep 2013;3:53-5.
Published
How to Cite
Issue
Section
Copyright (c) 2021 ARYA SATHYAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
